Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorWeill Medical College of Cornell University

About this trial

Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.

Eligibility criteria

Qualifiers

Adolescents age 12-17 years.

Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors.

Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment.

Disqualifiers

Started on a biologic agent (i.e. dupxient) within the past 3 months.

Mild atopic dermatitis via PO-SCORAD score on enrollment.

Trial design

Treatments tested in this trial

  • Digital App Mindfulness Meditation
  • Mindfulness Meditation Sheet

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators